Saturday, November 2, 2024
Home Tags Health-006-August-2018

Health-006-August-2018 Related News

Medicines for Europe: better access, better health

Medicines for Europe: better access, better health

Medicines for Europe president Marc-Alexander Mahl outlines the challenges facing the generic, biosimilar and value-added medicines industry and its role in achieving sustainable healthcare. Medicines...
The Support Hope and Recovery Online Network (SHaRON): transforming mental health with digital

The Support Hope and Recovery Online Network (SHaRON): transforming mental health with digital

Jonathon Burton, web and digital services manager at Berkshire Healthcare NHS Foundation Trust, talks about the trust’s Support Hope and Recovery Online Network (SHaRON),...
Health outcomes and the community pharmacist

Health outcomes and the community pharmacist

Ilaria Passarani, secretary general of PGEU, reflects on the invaluable role of the community pharmacist in improving patient health outcomes in Europe. Every day, some...
Good Clinical Practice across the NHS

Good Clinical Practice across the NHS

Health Europa discusses Good Clinical Practice, how it is monitored and the modern-day threats to clinical practice which could compromise the healthcare system. Good Clinical...
Getting to the heart of the matter: can we prevent cardiovascular disease?

Getting to the heart of the matter: can we prevent cardiovascular disease?

The dramatic increase in age-associated disorders such as cardiovascular disease represents a major burden on modern society. Researchers at the University of Leuven, Belgium,...
Looking to the future: harnessing data analytics to achieve truly integrated healthcare

Looking to the future: harnessing data analytics to achieve truly integrated healthcare

David Bolton, Qlik’s vice-president, industry solutions, marks the 70th anniversary of the NHS by looking at the transformative possibilities data analytics offers the service...
Diagnosis and delay: an approach to addressing diabetic kidney disease

Diagnosis and delay: an approach to addressing diabetic kidney disease

Health Europa takes a look at the causes, diagnosis and treatment of diabetic kidney disease and investigates what is being done at a European...
Welcome to the Kuopio Center for Gene and Cell Therapy

Welcome to the Kuopio Center for Gene and Cell Therapy

The Kuopio Center for Gene and Cell Therapy is home to the research and development of new innovative medicines. The Kuopio Center for Gene and...
Coeliac disease in children – a call to arms

Coeliac disease in children – a call to arms

Cases of coeliac disease in children continue to rise – and continue to go undetected across Europe. AOECS and ESPGHAN are campaigning to change...
Epigenetics: advancing diagnostics and accelerating precision medicine

Epigenetics: advancing diagnostics and accelerating precision medicine

Dr Jason Mellad, chief executive officer at Cambridge Epigenetix, discusses the emerging field of epigenetics-led diagnostics and personalised approaches to medicine. The exciting and rapidly...
Mapping immune signalling

Mapping immune signalling

Anders Linden on the mapping of immune signalling via the cytokine interleukin-26 to identify novel diagnostic and therapeutic targets in COPD. In the research group...
Competence makes thae difference in emergency medicine

Competence makes the difference in emergency medicine

Dr Roberta Petrino, president of the European Society for Emergency Medicine, shares with Health Europa her hopes for the inaugural Emergency Medicine Day. The European...
A&E: the canary in a changing world

A&E: the canary in a changing world

The A&E performance figures published this winter by NHS England were the worst since the four-hour target was introduced in 2004. Here, RCEM vice-president...
AMPK activator O304 – a novel treatment for Type 2 diabetes and diabetic kidney disease

AMPK activator O304 – a novel treatment for Type 2 diabetes and diabetic kidney...

The high and increasing unmet patient need in diabetic kidney disease demands new drugs. Betagenon AB has the answer. Globally, approximately 40% of Type 2...
Learning from the WannaCry ransomware attack

Learning from the WannaCry ransomware attack

More than one year on from the devastating WannaCry ransomware attack, Tanium’s Matt Ellard considers how far healthcare organisations are prepared to deal with...
The psychiatric patient and the ED - the evolution of emergency psychiatry

The psychiatric patient and the ED

Marc Sabbe discusses the evolution of emergency psychiatry, highlighting issues such as deinstitutionalisation and cost containment. There is no doubt that the amount and intensity...
Connecting patients with a rare digestive disorder to research and cures

Connecting patients with a rare digestive disorder to research and cures

Life with a rare digestive disorder often means suffering with disabling symptoms for years before receiving the correct diagnosis and appropriate care. Patient advocacy...
Towards a Decade of Healthy Ageing

Towards a Decade of Healthy Ageing

Dr Jane Barratt and Megan Acton, of the International Federation on Ageing, set out their vision of a Decade of Healthy Ageing from 2020...
Could lifestyle choices be linked to development of early-onset dementia?

Could lifestyle choices be linked to development of early-onset dementia?

Writing for Health Europa, Ella Hendrix explores whether lifestyle factors could play a role in rising levels of early-onset dementia. Early-onset dementia appears to be...

Pin It on Pinterest